S'abonner

Fate of manuscripts declined by the Journal of the American Academy of Dermatology - 24/04/13

Doi : 10.1016/j.jaad.2007.12.025 
April W. Armstrong, MD a, Shereene Z. Idriss, BA b, Alexandra B. Kimball, MD, MPH a, c, , Jeffrey D. Bernhard, MD d
a Brigham and Women’s Hospital, Clinical Unit for Research Trials in Skin, Boston, Massachusetts 
b George Washington School of Medicine and Health Sciences, Washington, District of Columbia 
c Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 
d University of Massachusetts Medical School, Worcester, Massachusetts 

Correspondence to: Alexandra B. Kimball, MD, MPH, Massachusetts General and Brigham and Women’s Hospitals, 50 Staniford Street, #246, Boston, MA 02114.

Abstract

Background

Submissions to the Journal of the American Academy of Dermatology (JAAD) undergo a rigorous peer-review process. However, little is known regarding the fate of manuscripts declined by the JAAD.

Objective

We sought to: (1) determine the proportion of manuscripts declined by the JAAD that are subsequently published elsewhere; (2) identify the journals in which they were published; and (3) study whether the authors of declined manuscripts adopted in their final publications the changes suggested by the JAAD reviewers.

Methods

We reviewed the outcomes of the 489 submissions declined by the JAAD during two 4-month periods: from March 1, 2004, to June 30, 2004, and from March 1, 2005, to June 30, 2005.

Results

Of the 981 manuscripts submitted to JAAD during the two 4-month periods studied, 489 manuscripts (50%) were declined. Among the declined manuscripts, 201 (41%) had been subsequently published in other medical journals as of March 1, 2007. Among the 55 journals that published manuscripts declined by JAAD, 23 (42%) were nondermatology journals. The median impact factor for these 55 journals was 1.638, compared with the JAAD’s impact factor of 2.402. Among the declined manuscripts, Case Reports comprised the largest proportion (n = 149, 31%), followed by Original Research Reports (n = 90, 18%). Overall, 46 (51%) rejected Original Research Reports were subsequently published, compared with 145 (36%) rejected submissions in other categories that were later published (P < .01). Among the 101 subsequently published manuscripts for which full texts were available, 82% of the authors incorporated at least one change suggested by the JAAD reviewers. The manuscripts that adopted JAAD-reviewer suggestions were published in journals with higher impact factors than those that did not incorporate any JAAD-reviewer suggestions (P = .0305).

Limitations

It is possible that the average lag time of 28 months in this study is not sufficient for some rejected manuscripts to reach subsequent publication.

Conclusions

Approximately half of the manuscripts rejected by the JAAD were subsequently published in other journals within 28 months, among which, roughly 40% went to nondermatology journals. The median impact factor of the journals that published JAAD-rejected manuscripts was lower than that of the JAAD. Rejected Original Research Reports have a significantly higher probability of being subsequently published than other category submissions. This may be a result of relative quality of Original Research Reports versus submissions for other sections of the journal (eg, Case Reports). Manuscripts that adopted JAAD-reviewer suggestions were subsequently published in journals with higher impact factors than those that did not incorporate JAAD-reviewer suggestions. This indicates that peer-reviewer comments can be useful and important for improving the quality of scientific publications.

Le texte complet de cet article est disponible en PDF.

Plan


 Funding sources: None.
 Disclosure: Dr Bernhard was the editor for and Dr Kimball was an associate editor for the Journal of the American Academy of Dermatology at the time the manuscript was accepted. Dr Armstrong and Ms Idriss have no conflicts of interest to declare.
 Reprints not available from the authors.


© 2008  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 58 - N° 4

P. 632-635 - avril 2008 Retour au numéro
Article précédent Article précédent
  • Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial
  • Shanu Kohli Kurd, Nana Smith, Abby VanVoorhees, Andrea B. Troxel, Vladimir Badmaev, John T. Seykora, Joel M. Gelfand
| Article suivant Article suivant
  • JAAD Authors’ Rights Information

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.